Interpretation of Elevated Alkaline Phosphatase with Normal Gamma‑Glutamyl Transferase

Enzyme Pattern and Diagnostic Significance

Gamma‑glutamyl transferase (GGT) acts as a gatekeeper to differentiate hepatic from non‑hepatic sources of an elevated alkaline phosphatase (ALP); it is present in liver, kidney, intestine, prostate, and pancreas but absent in bone. The presence of a normal GGT when ALP is raised strongly points to a non‑hepatic (most often bone) origin, whereas a concomitantly elevated GGT confirms a hepatic/cholestatic source. 1, 2, 3

Paget’s disease of bone is a common bone disorder that can produce isolated ALP elevation with normal GGT. 1, 2, 3
Metastatic bone disease (bony metastases) may raise ALP without affecting GGT. 1, 2, 3
Fracture healing leads to transient ALP increase while GGT remains normal. 1, 2, 3
Physiologic bone growth in children results in higher ALP levels; GGT stays within normal limits. 1, 2, 3
Pregnancy‑related placental ALP production can cause isolated ALP rise with normal GGT. 1, 2, 3

Intestinal ALP may be elevated in conditions such as inflammatory bowel disease or intestinal ischemia. 1, 2, 3
Renal ALP can rise in chronic kidney disease. 1, 2, 3
White‑blood‑cell ALP may be increased in hematologic malignancies (e.g., leukemia, lymphoma). 1, 2, 3

Do not assume liver disease solely on the basis of an elevated ALP when GGT is normal; most hepatic disorders that raise ALP also elevate GGT. This misinterpretation is a frequent error. 1, 2, 3
Rare hepatic scenarios (infiltrative diseases such as sarcoidosis, amyloidosis, hepatic metastases, or early/partial biliary obstruction) can present with elevated ALP and normal GGT, but these are uncommon and should be considered only after bone sources are excluded. 1, 2, 3

Verify that ALP is truly above the upper limit of normal and that GGT is within the reference range. 2
Check that transaminases (AST/ALT) are not markedly elevated, supporting a non‑hepatic pattern. 2

Obtain a bone‑specific ALP assay when available to confirm bone origin. 3
Review clinical history for bone pain, recent fractures, or known malignancy. 3
Perform targeted bone imaging (plain radiographs, bone scintigraphy, or CT/MRI) if the history suggests skeletal pathology. 3
Consider age‑ and sex‑related physiologic elevations (children, pregnant individuals). 1, 2, 3

Assess for intestinal sources (e.g., inflammatory bowel disease, intestinal ischemia). 4
Evaluate renal function for chronic kidney disease as a possible contributor. 3
Review hematologic status for leukemia or lymphoma. 2

If bone and other non‑hepatic causes are excluded and clinical suspicion for liver disease remains high, obtain an abdominal ultrasound as the first‑line hepatobiliary imaging study. 1, 2, 4

A normal GGT effectively rules out cholestatic liver disease as the primary cause of an elevated ALP; the initial diagnostic focus should therefore be on bone pathology, with hepatobiliary imaging reserved for cases where bone evaluation is unrevealing and clinical context strongly suggests liver involvement. 1, 2, 3